Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapies
Velia Chiara Di Maio(University of Rome Tor Vergata), M. Paoloni, Valeria Cento(Rostov State Medical University), Giovanni Battista Gaeta, Antonio Grieco(Università Cattolica del Sacro Cuore), C. D’Ambrosio, Gabriella d’Ettorre(Policlinico Umberto I), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Pierluigi Tarquini(Nini Hospital), Roberto Gulminetti(University of Pavia), Bianca Bruzzone(Ospedale Policlinico San Martino), Vincenza Calvaruso(University of Palermo), Stefania Paolucci(Policlinico San Matteo Fondazione), M. Melis(University of Sassari), Simona Landonio(ASST Fatebenefratelli Sacco), M. Aragri(University of Rome Tor Vergata), A. Picciotto(Fondazione Bruno Kessler), V. Boccaccio(Humanitas University), Mario Starace(Vita-Salute San Raffaele University), C. Pasquazzi(Azienda Ospedaliera Sant'Andrea), Letizia Marinaro(University of Turin), Gabriella Verucchi(University of Bologna), S. Francioso, Francesco Santopaolo(University of Rome Tor Vergata), Ivana Maida, Valeria Ghisetti(Ospedale Amedeo di Savoia), Giorgio Barbarini(Humanitas University), Vincenzo Sangiovanni(Ospedale Sant'Anna), Alessandro Mancon(Luigi Sacco Hospital), Teresa Pollicino(University of Messina), Dante Romagnoli(University of Modena and Reggio Emilia), F.P. Antonucci(University of Rome Tor Vergata), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Alessia Ciancio(Department of Medical Sciences), Laura Sticchi(Ospedale Policlinico San Martino), I. Lenci(University of Rome Tor Vergata), Alessia Giorgini(Università Cattolica del Sacro Cuore), T. Ruggiero, Pietro Andreoné, Valeria Micheli(ASST Fatebenefratelli Sacco), Raffaele Cozzolongo, Alessandro Bertoli(University of Padua), Manuela Merli(Policlinico Umberto I), Silvia Barbaliscia(University of Rome Tor Vergata), Jacopo Vecchiet(University of Chieti-Pescara), Valeria Pace Palitti(Azienda USL di Pescara), C. Magni(ASST Fatebenefratelli Sacco), Filomena Morisco, G. De Stefano, Antonio Di Biagio
Cited by 2
Related Papers
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†
|Hepatology|2009|1.4k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
EASL Clinical Practice Guidelines on nutrition in chronic liver disease
|Journal of Hepatology|2018|1k
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
|Gastroenterology|2018|513